The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Open accessAbstract
Fibrillar amyloid-beta (Aβ) is found in the brains of many cognitively normal older people. Whether or not this reflects a predisposition to Alzheimer's disease (AD) is unknown. We used Pittsburgh Compound B (PiB) PET to characterize the relationship between fibrillar Aβ burden and this predisposition in cognitively normal older people at 3 mean levels of genetic risk for AD. Dynamic PiB PET scans, the Logan method, statistical parametric mapping, and automatically labeled regions of interest (ROIs) were used to characterize and compare cerebral-to-cerebellar PIB distribution volume ratios, reflecting fibrillar Aβ burden, in 28 cognitively normal persons (mean age, 64 years) with a reported family history of AD and 2 copies, 1 copy, and no copies of the apolipoprotein E (APOE) ε4 allele. The 8 ε4 homozygotes, 8 heterozygotes, and 12 noncarriers did not differ significantly in terms of age, sex, or cognitive scores. Fibrillar Aβ was significantly associated with APOE ε4 carrier status and ε4 gene dose in AD-affected mean cortical, frontal, temporal, posterior cingulate-precuneus, parietal, and basal ganglia ROIs, and was highest in an additional homozygote who had recently developed mild cognitive impairment. These findings suggest that fibrillar Aβ burden in cognitively normal older people is associated with APOE ε4 gene dose, the major genetic risk factor for AD. Additional studies are needed to track fibrillar Aβ accumulation in persons with different kinds and levels of AD risk; to determine the extent to which fibrillar Aβ, alone or in combination with other biomarkers and risk factors, predicts rates of cognitive decline and conversion to clinical AD; and to establish the role of fibrillar Aβ imaging in primary prevention trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Crossing a transgenic mouse model of AD that has high levels of human Aβ in the brain with human APOE targeted replacement mice demonstrated age-dependent and APOE isoform-dependent (E4>>E3>E2) Aβ deposition and amyloid burden in the brain in a manner that recapitulates the human condition observed in pre-symptomatic elderly APOE4 carriers as well as AD patients.18–21”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the amyloid deposition spreads, and the disease pathogenesis progressively involves a broad region of the brain”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The association of the APOE4 isoform with amyloid deposition has been well established in human studies, where APOE4 carriers exhibit higher A β plaque burden and earlier onset of amyloid positivity compared with non-carriers 35 -37 .”
From APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE status has been found to modulate the onset of extracellular amyloid plaque deposition, one of the key pathognomonic features of the disease (6, 7).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the APOE ε4 allele increases brain amyloid burden assessed by PIB-PET imaging in a gene dose-dependent manner (6).”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [6]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE isoform-dependent amyloid deposition has been consistently observed in humans and Aβ depositing mouse models (Holtzman et al., 2000; Bales et al., 2009; Reiman et al., 2009; Morris et al., 2010).”
From Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis (2011) · cites this paper as Reiman et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ε4 allele increased brain amyloid burden in a dose-dependent manner in normal elderly individuals and in mild cognitive impairment patients [93,94].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [93]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This finding has now been confirmed more directly in a study that showed cognitively normal subjects had an ε4 dose-dependent increase in fibrillar Aβ burden in brain as detected with an amyloid imaging agent (Reiman et al., 2009).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Reiman et al., 2009
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This possibility has remained unaddressed, because case–control studies without neuropathological or biomarker assessments of AD may have underestimated the impact of APOE genotypes on Alzheimer’s dementia ORs due to the confounding effects of APOE genotypes on the percentages of neuropathologically misclassified cases and controls8–10.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Due to the prioritized ascertainment of those cases who met the clinical and neuropathological criteria for Alzheimer’s dementia and those unimpaired controls without AD, the number of misclassified cases and controls available through the AD Genetics Consortium12 is much smaller than our estimated number of neuropathologically misclassified cases and controls8–11, limiting our ability to clarify”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In a previous autopsy study, we found that 25% of persons with the clinical diagnosis of mild-to-moderate Alzheimer’s dementia lacked at least moderately frequent neuritic plaques, one of the cardinal features of AD, including 37% of APOE4 non-carriers and 13% of carriers, findings that are consistent with those in living patients9,10.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 1×
“The APOE 4 allele is associated with increased cerebral and vascular A deposition in AD (25), and the ApoE E4 isoform is associated with increased A binding, fibrillization, and cerebral and vascular A deposition (13, 26), as well as with decreased ApoE-mediated A clearance and degradation (27–29).”
BackgroundRestriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Cited by
Sorted by citations
Items 501–600 of 787
Molecular Brain Imaging in the Multimodality Era
Price, J. C. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.29 · Cited by 16
Self-citationCai, S., Jiang, Y., Wang, Y., Wu, X., Ren, J., Lee, M. S., Lee, S., & Huang, L. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.027 · Cited by 16
Kang, K. M., Sohn, C., Byun, M. S., Lee, J. H., Yi, D., Lee, Y., Lee, J., Kim, Y. K., Sohn, B. K., Yoo, R., et al. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s252293 · Cited by 16
Snellman, A., Ekblad, L. L., Koivumäki, M., Lindgrén, N., Tuisku, J., Perälä, M., Kallio, L., Lehtonen, R., Saunavaara, V., Saunavaara, J. P., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.826423 · Cited by 15
Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?
Steele, J., & Gandy, S. (2011) · Annals of Neurology · doi:10.1002/ana.22359 · Cited by 16
Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring
Maye, J. E., Betensky, R. A., Gidicsin, C. M., Locascio, J. J., Becker, J. A., Pepin, L. C., Carmasin, J. S., Rentz, D. M., Marshall, G. A., Blacker, D., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.013 · Cited by 16
Lee, S. H., Byun, M. S., Yi, D., Kim, M. J., Jung, J. H., Kong, N., Jung, G., Ahn, H., Lee, J., Kang, K. M., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01259-w · Cited by 15
Risk factors for amyloid positivity in older people reporting significant memory concern
Zhang, J., Zhou, W., Cassidy, R. M., Su, H., Su, Y., & Zhang, X. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.09.015 · Cited by 17
Namiki, C., Takita, Y., Iwata, A., Momose, T., Senda, M., Okubo, Y., Joshi, A. D., Lu, M., Agbulos, A., Breault, C., et al. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-0978-2 · Cited by 15
Epigenetic plasticity and redox regulation of neural stem cell state and fate
Tay, E. X. Y., Chia, K., & Ong, D. S. T. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.030 · Cited by 15
Wang, J., Wang, M., Ren, S., Huang, L., He, K., Li, J., Hua, F., Guan, Y., Guo, Q., Huang, Q., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221166 · Cited by 15
Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding
Lazaris, A. S., Hwang, K., Goukasian, N., Ramirez, L. M., Eastman, J. A., Blanken, A. E., Teng, E., Gylys, K. H., Cole, G. M., Saykin, A. J., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000022 · Cited by 15
Amyloid + Activation = Alzheimer's?
Jagust, W. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.008 · Cited by 16
APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum
Mares, J. A., Kumar, G., Sharma, A., Emrani, S., McIntire, L. B., Guo, J., Menon, V., Nuriel, T., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14392 · Cited by 16
Gao, Y., Wei, S., Gao, F., Gao, L., Dang, L., Shang, S., Chen, C., Huo, K., Wang, J., Wang, J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615838 · Cited by 15
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories
Jang, H., Chun, M. Y., Yun, J., Kim, J. P., Kang, S. H., Weiner, M. W., Kim, H. J., Na, D. L., Hong, C., Son, S. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14247 · Cited by 15
Phenome-wide association of APOE alleles in the All of Us Research Program
Khajouei, E., Ghisays, V., Piras, I. S., Martinez, K. L., Vicenti, A. T., Naymik, M., Ngo, P., Tran, T. C., Denny, J. C., Wheeler, T. J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105768 · Cited by 14
Self-citationApolipoprotein E genotype and in vivo amyloid burden in middle-aged Hispanics
Palta, P., Rippon, B., Reitz, C., He, H., Sherwood, G., Ceballos, F., Teresi, J. A., Razlighi, Q. R., Moreno, H., Brickman, A. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010707 · Cited by 14
Initiative, A. D. N., Chiotis, K., Carter, S. F., Farid, K., Savitcheva, I., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3115-5 · Cited by 16
Salomon‐Zimri, S., Liraz, O., & Michaelson, D. M. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.014 · Cited by 14
Reinvang, I., Lundervold, A. J., Wehling, E. I., Rootwelt, H., & Espeseth, T. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710000263 · Cited by 14
Wang, H.-Y., Trocmé, C., Stucky, A., Shah, S. M., Kvasic, J., Khan, A., Morain, P., Guignot, I., Bouguen, E., Deschet, K., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0280-8 · Cited by 14
RetractedTsai, C., Sun, H., Kuo, Y., & Pai, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101639 · Cited by 15
Insights into cognitive aging and Alzheimer’s disease using amyloid PET and structural MRI scans
Duara, R., Barker, W., Loewenstein, D., Greig, M. T., Rodriguez, R. A., Goryawala, M., Zhou, Q., & Adjouadi, M. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0110-6 · Cited by 15
Fibrillar amyloid correlates of preclinical cognitive decline
Stonnington, C. M., Chen, K., Lee, W., Locke, D. E. C., Dueck, A. C., Liu, X., Roontiva, A., Fleisher, A., Caselli, R. J., & Reiman, E. M. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.009 · Cited by 13
Self-citationKuang, L., Jia, J., Zhao, D., Xiong, F., Han, X., Wang, Y., & Initiative, A. D. N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00188 · Cited by 13
Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention?
Reinvang, I. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00143 · Cited by 13
Frequency Specific Effects of ApoE ε4 Allele on Resting-State Networks in Nondemented Elders
Liang, Y., Li, Z., Jing, W., Li, C., Zhang, X., & Initiative, A. D. N. (2017) · BioMed Research International · doi:10.1155/2017/9823501 · Cited by 13
Koller, E. J., Cruz, E. G. D. L., Weinrich, M. J., Williams, T., Cruz, P. E., Ryu, D. H., Golde, T. E., Sullivan, P. M., Lewis, J. M., Borchelt, D., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01859-4 · Cited by 13
Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer’s disease
Biel, D., Suárez‐Calvet, M., Dewenter, A., Steward, A., Roemer, S. N., Dehsarvi, A., Zhu, Z., Pescoller, J., Frontzkowski, L. K., Kreuzer, A., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00190-3 · Cited by 16
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 14
Circadian rest‐activity rhythm and longitudinal brain changes underlying late‐life cognitive decline
Jeon, S. Y., Byun, M. S., Yi, D., Jung, G., Lee, J., Kim, Y. K., Sohn, C., Kang, K. M., Lee, Y. J., & Lee, D. Y. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13521 · Cited by 12
Lee, S. H., Byun, M. S., Lee, J. H., Yi, D., Sohn, B. K., Lee, J., Kim, Y. K., Shin, S. A., Sohn, C., Lee, D. Y., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191216 · Cited by 12
Martí‐Juan, G., Sanromà, G., Cacciaglia, R., Falcón, C., Operto, G., Molinuevo, J. L., Ballester, M. Á. G., Gispert, J. D., Piella, G., Initiative, T. A. D. N., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.25202 · Cited by 12
Amyloid PET in neurodegenerative diseases with dementia
Camacho, V., Gómez‐Grande, A., Sopena, P., Solís, D. G., Río, M. G., Lorenzo‐Bosquet, C., Rubí, S., & Arbizu, J. (2018) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2018.04.003 · Cited by 12
Role of Amyloid β1–42 and Neuroimaging Biomarkers in Alzheimer‘s Disease
Lista, S., & Emanuele, E. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.50 · Cited by 12
A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease
Bai, H., Naj, A. C., Benchek, P. H., Dumitrescu, L. C., Hohman, T. J., Hamilton‐Nelson, K. L., Kallianpur, A. R., Griswold, A. J., Vardarajan, B. N., Martin, E. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13050 · Cited by 11
Stewart, C. C., Boyle, P. A., James, B. D., Yu, L., Han, S. D., & Bennett, D. A. (2016) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbw054 · Cited by 11
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease
Ramanan, V. K., Heckman, M. G., Lesnick, T. G., Przybelski, S. A., Cahn, E. J., Kosel, M., Murray, M. E., Mielke, M. M., Botha, H., Graff‐Radford, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02419-2 · Cited by 10
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease
Pradhan, L. K., Sahoo, P. K., Chauhan, S., & Das, S. K. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02009-7 · Cited by 11
The concept of FDG-PET endophenotype in Alzheimer’s disease
During, E., Osorio, R. S., Elahi, F. M., Mosconi, L., & de Leon, M. J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0633-1 · Cited by 14
Structural imaging in early pre-states of dementia
Smith, C. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.002 · Cited by 11
Sohn, B. K., Byun, M. S., Yi, D., Jeon, S. Y., Lee, J. H., Choe, Y. M., Lee, D. W., Lee, J., Kim, Y. K., Sohn, C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215258 · Cited by 12
Amyloid imaging in Alzheimer's disease: A literature review
Saidlitz, P., Voisin, T., Vellas, B. J., Payoux, P., Gabelle, A., Formaglio, M., & Delrieu, J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0507-3 · Cited by 12
Brugulat‐Serrat, A., Sánchez‐Benavides, G., Cacciaglia, R., Salvadó, G., Shekari, M., Collij, L. E., Buckley, C. J., van Berckel, B. N. M., Perissinotti, A., Niñerola‐Baizán, A., et al. (2023) · EJNMMI Research · doi:10.1186/s13550-023-00967-6 · Cited by 10
Mecca, A. P., Ashton, N. J., Chen, M., O’Dell, R. S., Toyonaga, T., Zhao, W., Young, J. J., Salardini, E., Bates, K. A., Ra, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70344 · Cited by 10
Synergistic Effect of Serum Homocysteine and Diabetes Mellitus on Brain Alterations
Byeon, G., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Ko, K., Jung, G., Lee, J., Kim, Y. K., Lee, Y., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210036 · Cited by 11
Molecular neuroimaging in degenerative dementias
Jiménez-Bonilla, J. F., & CARRIL, J. M. (2013) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2013.07.027 · Cited by 10
Jeon, S. Y., Yi, D., Byun, M. S., Choi, H. J., Kim, H. J., Lee, J. H., Baek, H., Choe, Y. M., Lee, Y., Woo, J. I., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.045 · Cited by 10
Grilli, M. D., Woolverton, C. B., Crawford, M. S., & Glisky, E. L. (2017) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2016.1275508 · Cited by 12
Moon, S. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Lee, Y., Kee, B. S., & Lee, D. Y. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly157 · Cited by 10
Cacciaglia, R., Molinuevo, J. L., Falcón, C., Arenaza‐Urquijo, E. M., Sánchez‐Benavides, G., Brugulat‐Serrat, A., Blennow, K., Zetterberg, H., Gispert, J. D., study, F. T. A., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa034 · Cited by 9
Hu, H., Ma, L., Hu, H., Bi, Y., Ma, Y., Shen, X., Ou, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00383-5 · Cited by 11
Kim, H. J., Park, J., Jung, K. S., Kim, J., Jang, J. S., Kwon, S., Byun, M. S., Yi, D., Byeon, G., Jung, G., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00638-3 · Cited by 13
The Role of APOE and NF-κB in Alzheimer’s Disease
Davies, D. A. (2021) · Immuno · doi:10.3390/immuno1040027 · Cited by 10
Sajadi, A., Provost, C., Pham, B., & Brouillette, J. (2016) · Journal of Visualized Experiments · doi:10.3791/54215 · Cited by 10
An Emerging Role for Imaging White Matter in the Preclinical Risk for Alzheimer Disease
Alexander, G. E. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4123 · Cited by 10
Self-citationCaselli, R. J., Drazkowski, J. F., & Wingerchuk, D. M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0536 · Cited by 10
Self-citationThe Brain Network Hub Degeneration in Alzheimer’s Disease
Jin, S., Wang, J., & Yong He, A. (2024) · Biophysics Reports · doi:10.52601/bpr.2024.230025 · Cited by 11
Locus coeruleus tau is linked to successive cortical tau accumulation
Yi, D., Byun, M. S., Jung, J. H., Jung, G., Ahn, H., Chang, Y. Y., Keum, M., Lee, J., Lee, Y., Kim, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14426 · Cited by 8
Zhang, P.-F., Wang, Z.-T., Liu, Y., Hu, H., Sun, Y., Hu, H.-Y., Ma, Y.-H., Tan, L., & Yu, J.-T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220057 · Cited by 9
Enlarged perivascular spaces are associated with decreased brain tau deposition
Kang, K. M., Byun, M. S., Yi, D., Lee, K. H., Kim, M. J., Ahn, H., Jung, G., Lee, J., Kim, Y. K., Lee, Y., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14040 · Cited by 9
Mourtzi, N., Charisis, S., Tsapanou, A., Ntanasi, E., Hatzimanolis, A., Ramı́rez, A., Heilmann‐Heimbach, S., Grenier‐Boley, B., Lambert, J., Yannakoulia, M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12980 · Cited by 9
O’Dell, R. S., Higgins‐Chen, A., Gupta, D., Chen, M., Naganawa, M., Toyonaga, T., Lu, Y., Ni, G. S., Chupak, A., Zhao, W., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103457 · Cited by 9
The current state of apolipoprotein E in dyslipidemia
Rasmussen, K. L., & Frikke‐Schmidt, R. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000915 · Cited by 11
Shukla, D., Suryavanshi, A., Bharti, S. K., Asati, V., & Mahapatra, D. K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299847240328045737 · Cited by 10
APOE-ε4 Allele Altered the Rest-Stimulus Interactions in Healthy Middle-Aged Adults
Yan, F., Wu, C. W., Chao, Y., Chen, C.-J., & Tseng, Y.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128442 · Cited by 10
Byun, M. S., Choe, Y. M., Sohn, B. K., Yi, D., Han, J., Park, J., Choi, H. J., Baek, H., Lee, J. H., Kim, H. J., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00236 · Cited by 9
Guo, Y., Yang, Y., Zhang, Y.-R., Huang, Y., Chen, K., Chen, S.-D., Dong, P. Q., & Yu, J.-T. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.09.002 · Cited by 9
Self-citationBarnes, J., Initiative, A. D. N., Bartlett, J. W., Fox, N. C., & Schott, J. M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121936 · Cited by 9
From mild cognitive impairment to prodromal Alzheimer disease: A nosological evolution
Molinuevo, J. L., Valls‐Pedret, C., & Rami, L. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.05.003 · Cited by 12
Vilor‐Tejedor, N., Operto, G., Evans, T. E., Falcón, C., Crous‐Bou, M., Minguillón, C., Cacciaglia, R., Milà‐Alomà, M., Grau‐Rivera, O., Suárez‐Calvet, M., et al. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02125-3 · Cited by 9
Daly, J., Luca, F. D., Berens, S. C., Field, A. P., Rusted, J. M., & Bird, C. M. (2024) · Cortex · doi:10.1016/j.cortex.2024.05.006 · Cited by 10
Moderation of thyroid hormones for the relationship between amyloid and tau pathology
Byeon, J. H., Byun, M. S., Yi, D., Jung, J. H., Sohn, B. K., Chang, Y. Y., Kong, N., Jung, G., Ahn, H., Lee, J., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01534-4 · Cited by 8
Salardini, E., O’Dell, R. S., Tchorz, E., Nabulsi, N., Huang, Y. H., Carson, R. E., van Dyck, C. H., & Mecca, A. P. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01739-1 · Cited by 8
Association of Central Auditory Processing Dysfunction With Preclinical Alzheimer's Disease
Byun, M. S., Chang, M. Y., Yi, D., Ahn, H., Han, D., Jeon, S., Jang, H., Lee, D. Y., & Oh, S. H. (2023) · Otolaryngology · doi:10.1002/ohn.228 · Cited by 8
The Aging Patterns of Brain Structure, Function, and Energy Metabolism
Dang, M., Sang, F., Long, S., & Chen, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1627-6_7 · Cited by 8
Niu, X., Wang, Y., Zhang, X., Wang, Y., Shao, W., Chen, L., Yang, Z., & Peng, D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07028-9 · Cited by 10
Park, J. K., Byun, M. S., Yi, D., Ahn, H., Jung, J. H., Kong, N., Chang, Y. Y., Jung, G., Lee, J., Kim, Y. K., et al. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1189 · Cited by 8
Alzheimer's Prevention Initiative
Strobel, G. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101429 · Cited by 8
del Val, L. P., Cantero, J. L., & Atienza, M. (2015) · Hippocampus · doi:10.1002/hipo.22422 · Cited by 9
La neuroimagen molecular en las demencias degenerativas
Jiménez-Bonilla, J. F., & CARRIL, J. M. (2013) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2013.06.012 · Cited by 9
Su, S.-S., Chen, K.-W., & Huang, Q. (2014) · Journal of Shanghai Jiaotong University (Science) · doi:10.1007/s12204-014-1540-4 · Cited by 8
Self-citationPolyglucosan Bodies in Aged Brain and Neurodegeneration: Cause or Consequence?
Rai, A., & Ganesh, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3585-3_4 · Cited by 8
PET amiloide en enfermedades neurodegenerativas que cursan con demencia
Camacho, V., Gómez‐Grande, A., Sopeña, P., García-Solís, D., Río, M. G., Lorenzo‐Bosquet, C., Rubí, S., & Arbizu, J. (2018) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2018.03.004 · Cited by 9
Rogojin, A., Gorbet, D. J., Hawkins, K. M., & Sergio, L. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1054523 · Cited by 7
Barnes, C. A., Permenter, M. R., Vogt, J. A., Chen, K., & Beach, T. G. (2024) · The Journal of Comparative Neurology · doi:10.1002/cne.25670 · Cited by 8
Self-citationAfrakoti, L. G. M. P., Moghadam, S. D., & Hadinezhad, P. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251329188 · Cited by 12
Dasadhikari, S., Ghosh, S., Pal, S., Knowles, T. P. J., & Garai, K. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01524-z · Cited by 9
Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
Sil, M., Mukherjee, N., Chatterjee, I., Ghosh, A., & Goswami, A. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02379-8 · Cited by 9
Neue diagnostische Methoden bei Demenzen
Wiltfang, J. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4177-5 · Cited by 5
Spouse bereavement and brain pathologies: A propensity score matching study
Kim, J. W., Byun, M. S., Lee, J. H., Yi, D., Kim, M. J., Jung, G., Lee, J., Lee, Y., Kim, Y. K., Kang, K. M., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13439 · Cited by 7
Association of low meal frequency with decreased in vivo Alzheimer’s pathology
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Sung, K., Han, D., Byeon, G., Kim, M. J., Jung, J. H., Chang, Y. Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105422 · Cited by 9
Gao, P., Ou, Y., Huang, Y., Wang, Z., Fu, Y., Ma, Y., Li, Q., Ma, L., Cui, R., Mi, Y., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16025 · Cited by 7
Han, S., Byun, M. S., Yi, D., Jung, J., Kong, N., Chang, Y. Y., Keum, M., Jung, G. J., Lee, J.-Y., Lee, Y. S., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.131 · Cited by 8
Pardo, J. V., Lee, J. T., & Initiative, A. D. N. (2018) · eNeuro · doi:10.1523/eneuro.0396-17.2018 · Cited by 8
Label‐Free DNA Sensors Based on Field‐Effect Transistors with Semiconductor of Carbon Materials
Zhao, L., Cao, D., Gao, Z., Mi, B., & Huang, W. (2015) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201500254 · Cited by 7
Beyond diagnosis: What biomarkers are teaching us about the “bio”logy of Alzheimer disease
Rabinovici, G. D., & Roberson, E. D. (2010) · Annals of Neurology · doi:10.1002/ana.22020 · Cited by 7
Rubenstein, R. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-012-0020-7 · Cited by 8
The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism
Lyons, C. E., Tudorascu, D., Snitz, B. E., Price, J. C., Aizenstein, H. J., López, O. L., Lopresti, B. J., Laymon, C. M., Minhas, D. S., Kamboh, M. I., et al. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.03.018 · Cited by 10
Self-citation
Metadata
- Authors
- Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., Alexander, G. E., Klunk, W. E., Mathis, C. A., Price, J. C., Aizenstein, H. J., DeKosky, S. T., & Caselli, R. J.
- Affiliations
- Translational Genomics Research Institute (US)
- Banner - University Medical Center Phoenix (US)
- University of Arizona (US)
- Departments of iPsychiatry,
- University of Pittsburgh (US)
- Mayo Clinic in Arizona (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-21
- Volume
- 106
- Issue
- 16
- Pages
- 6820-6825
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2665196
- OpenAlex
- W2171346860
- Semantic Scholar
- 50d5adab23ba1a800626a6f613f94a2c667b07e4
- Cited by
- 785
- References
- 44
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 34 · 2023: 36 · 2022: 36 · 2021: 45 · 2020: 44 · 2019: 39 · 2018: 34 · 2017: 34 · 2016: 40 · 2015: 50 · 2014: 66 · 2013: 61 · 2012: 65
- FWCI
- 45.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McKnight Foundation
- National Institute on Aging (R01AG025526, R01AG018402, P01AG025204, RF1AG025516, P50AG005133, R01AG031581, P30AG019610, R37AG025516)
- National Institute of Mental Health (R01MH070729, R01MH057899)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- fibrillar amyloid-beta, Alzheimer's disease, APOE ε4, genetic risk, cognitively normal older adults, Pittsburgh compound B PET, family history of Alzheimer's disease, mild cognitive impairment, primary prevention
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cognition, Heterozygote, Homozygote, Humans, Magnetic Resonance Imaging, Middle Aged, Neuropsychological Tests, Amyloid beta-Peptides, Gene Dosage, Genetic Predisposition to Disease, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
